Tri-Conference Press Pass

Required Credentials for Press & Analysts

Cambridge Healthtech Institute invites accredited media working for scientific news journal/magazine/newspaper to register for a complimentary press pass for the Molecular Medicine Tri-Conference.

Due to high demand, press passes are limited in number and will be issued only to representatives from news outlets, major analyst firms and leading industry blogs. To qualify for a complimentary press pass, the applicant must cover the life sciences industry on a regular basis and present bylined articles or reports published within the past six months upon registration, as well as provide a schedule to when conference coverage will be published.

Who qualifies for a press pass:

  • Publishers, marketing/PR professionals, account management, sales or C-level non-media titles will not be accepted.
  • Press passes are not issued to those writing confidential content or content solicited by an exhibiting company.
  • Private consultants paid by an individual company are not eligible for a press pass and should request a pass from the sponsoring company.
  • Press credentials granted for previous CHI conference do not guarantee a press pass.
  • Video and or audio recording of any kind is prohibited onsite at all CHI events.

We reserve the right to request documentation regarding credentials and the right to refuse press passes without cause. Press representing organizations the produce competitive conferences are not allowed to suitcase onsite, and will not be granted access in the future.

Your Information:

How did you first find out about this CHI Conference?: (check one only)

Please email a copy of your completed article, along with the anticipated publish date to Jennifer Salhus at

Register Now
March 26-27, 2024

AI in Precision Medicine

Implementing Precision Medicine

At-Home & Point-of-Care Diagnostics

Liquid Biopsy

Spatial Biology

March 27-28, 2024

AI in Diagnostics

Diagnostics Market Access

Infectious Disease Diagnostics

Multi-Cancer Early Detection

Single-Cell Multiomics